This section is not available in the published analysis.
Transition Bio: Audience
Transition Bio offers a proprietary drug discovery platform that utilizes condensate technology to advance therapeutics targeting intractable biological challenges. The platform combines droplet microfluidics and machine learning to enhance drug discovery processes.